The regulation of sympathetic nerve activity by angiotensin II involves reactive oxygen species and MAPK

Circulation Research

Volumn 97, Issue 8, 2005, Pages 737-739

  Zucker, Irving H ^a,b   Gao, Lie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autonomic nerve activity; ROS; RVLM; Superoxide

Indexed keywords

4 AMINOBUTYRIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; GLUTAMIC ACID; GLYCOPROTEIN GP 91; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCTAPEPTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

EDITORIAL; ENZYME PHOSPHORYLATION; EXCITATION; HUMAN; HYPOTHALAMUS; NERVE CELL EXCITABILITY; NERVE CONDUCTION; PRIORITY JOURNAL; SYMPATHETIC NERVE; THALAMUS VENTRAL NUCLEUS;

ANGIOTENSIN II; ANIMALS; MEDULLA OBLONGATA; NADPH OXIDASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM;

EID: 26844538490     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000188261.94569.1f     Document Type: Editorial

References (39)

1. Alexander RS. Tonic and reflex functions of medullary sympathetic cardiovascular centers. J Neurophysiol. 1946;9:205-217.
2. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000;13:99S-105S.
3. Mancia G. Sympathetic activation in congestive heart failure. Europ Heart J. 1990;11(suppl A):3-11.
4. Ruffolo RR Jr, Feuerstein GZ. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. J Cardiovasc Pharmacol. 1998;32(Suppl 1):S22-S30.
5. Zucker IH, Patel KP, Schultz HD, Li YF, Wang W, Pliquett RU. Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev. 2004;32:107-111.
6. 1 receptors in the central control of sympathetic vasomotor function. Clin Exp Pharmacol Physiol. 1996;23:S93-S98.
7. Hu L, Zhu DN, Yu Z, Wang JQ, Sun ZJ, Yao T. Expression of angiotensin II type 1 (AT(1)) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol. 2002;92:2153-2161.
8. Saigusa T, Iriki M, Arita J. Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla. Am J Physiol Heart Circ Physiol. 1996;271:H1015-H1021.
9. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab. 1992;262:E763-E778.
10. Mangiapane ML, Simpson JB. Subfornical organ: forebrain site of pressor and dipsogenic action of angiotensin II. Am J Physiol Regul Integr Comp Physiol. 1980;239:R382-R389.
11. Mendelsohn FAO, Allen AM, Clevers J, Denton DA, Tarjan E, McKinley MJ. Localization of Angiotensin II receptor binding in rabbit brain by in vitro autoradiography. J Comp Neurol. 1988;270:372-384.
12. Oldfield BJ, Allen AM, Hards DK, McKinley MJ, Schlawe I, Mendelsohn FAO. Distribution of angiotensin II receptor binding in the spinal cord of the sheep. Brain Res. 1994;650:40-48.
13. 1 receptors in the brain. Regul Pept. 1993;44:95-107.
14. Potts PD, Allen AM, Horiuchi J, Dampney RAL. Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? Am J Physiol Regul Integr Comp Physiol. 2000 October; 279:R1392-R1402.
15. Chan SHH, Hsu K-S, Huang C-C, Wang L-L, Ou C-C, Chan JYH. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res. 2005;97:772-780.
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
17. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin signaling. Regulatory Peptides. 2000;9:21-27.
18. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000;105:1631-1639.
19. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002;106:3073-3078.
20. 1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res. 2002;90:617-624.
21. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res. 2004 February 20;94:402-409.
22. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang YL, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res. 2004;95:532-539.
23. 1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271-H2279.
24. El Bekay R, Alvarez M, Monteseirin J, Alba G, Chacon P, Vega A, Martin-Nieto J, Jimenez J, Pintado E, Bedoya FJ, Sobrino F. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood. 2003;102:662-671.
25. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029.
26. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. FGF ans stress regulate CREB and ATF-1 via a pathway involving p38 MAPK and MAPKAP kinase-2. EMBO J. 1996;15:4629-4642.
27. Janknecht R, Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 1997;16:1620-1627.
28. Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science. 1996;272:1347-1349.
29. Merlo D, Cifelli P, Cicconi S, Tancredi V, Avoli M. 4-Aminopyridine- induced epileptogenesis depends on activation of mitogen-activated protein kinase ERK. J Neurochem. 2004;89:654-659.
30. Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res. 2002;55:681-689.
31. Varga AW, Anderson AE, Adams JP, Vogel H, Sweatt JD. Input-specific immunolocalization of differentially phosphorylated Kv4.2 in the mouse brain. Learn Mem. 2000;7:321-332.
32. Soto MA, Gonzalez C, Lissi E, Vergara C, Latorre R. Ca(2+)-activated K+ channel inhibition by reactive oxygen species. Am J Physiol Cell Physiol. 2002;282:C461-C471.
33. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension. 2005;45:717-723.
34. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol 1997;80:7L-14L.
35. Zucker IH, Wang W, Brändle M, Schultz HD, Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovas Dis. 1995;37:397-414.
36. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res. 2004;95:937-944.
37. Dai WJ, Funk A, Herdegen T, Unger T, Culman J. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke. 1999;30:2391-2398.
38. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, Simon FR. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J. 2004;378:919-928.
39. Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis. 2004;25:249-261.